These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9786487)

  • 1. Comparison of the 5 microg disc and the Neo-Sensitab for determining the susceptibilities of Staphylococcus aureus isolates to mupirocin.
    Finlay JE; Miller LA; Poupard JA
    J Antimicrob Chemother; 1998 Sep; 42(3):403-5. PubMed ID: 9786487
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin.
    Palepou MF; Johnson AP; Cookson BD; Beattie H; Charlett A; Woodford N
    J Antimicrob Chemother; 1998 Nov; 42(5):577-83. PubMed ID: 9848440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mupirocin susceptibility in Staphylococcus aureus nasal and oropharyngeal isolates from Brazilian children.
    Pereira MF; Berezin EN; Carvalho RL; Scheffer DK; Mimica MJ
    J Chemother; 2014 Dec; 26(6):373-4. PubMed ID: 24621161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mupirocin resistance in clinical isolates of Staphylococcus aureus.
    Jones PG; Sura T; Harris M; Strother A
    Infect Control Hosp Epidemiol; 2003 Apr; 24(4):300-1. PubMed ID: 12725362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of disc diffusion methods and Vitek 2 automated system for testing susceptibility to mupirocin in Staphylococcus aureus.
    Malaviolle X; Nonhoff C; Denis O; Rottiers S; Struelens MJ
    J Antimicrob Chemother; 2008 Nov; 62(5):1018-23. PubMed ID: 18765413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mupirocin resistance in Staphylococcus aureus in an Indian hospital.
    Gadepalli R; Dhawan B; Mohanty S; Kapil A; Das BK; Chaudhry R; Samantaray JC
    Diagn Microbiol Infect Dis; 2007 May; 58(1):125-7. PubMed ID: 17240103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mupirocin susceptibility of nasal and nonnasal Staphylococcus aureus isolates.
    Utrup LJ; Finlay JE; Rittenhouse SF; Poupard JA
    Diagn Microbiol Infect Dis; 1994 Nov; 20(3):171-4. PubMed ID: 7874886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcus aureus highly resistant to mupirocin is now common in Auckland.
    Skellem P; Toy G; Lang S
    N Z Med J; 1998 Mar; 111(1061):82. PubMed ID: 9549560
    [No Abstract]   [Full Text] [Related]  

  • 9. Mupirocin resistance of methicillin resistant staphylococcus aureus in Saudi Arabia.
    Rich M; Bannatyne RM; Memish ZA
    J Chemother; 1999 Oct; 11(5):414-5. PubMed ID: 10632391
    [No Abstract]   [Full Text] [Related]  

  • 10. Staphylococcus aureus isolates from nares of orthopaedic patients in Sweden are mupirocin susceptible.
    Magnusson C; Stegger M; Hellmark B; Stenmark B; Söderquist B
    Infect Dis (Lond); 2019 Jun; 51(6):475-478. PubMed ID: 30985251
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro susceptibility of Staphylococcus aureus isolated from burn wounds to mupirocin and other antibiotics.
    Bulanda M; Tomanek E; Sakiel S; Heczko PB
    J Chemother; 1989 Jul; 1(4 Suppl):395-6. PubMed ID: 16312456
    [No Abstract]   [Full Text] [Related]  

  • 12. Susceptibility of methicillin-resistant Staphylococcus aureus to tea tree oil and mupirocin.
    Elsom GK; Hide D
    J Antimicrob Chemother; 1999 Mar; 43(3):427-8. PubMed ID: 10223605
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001.
    Kresken M; Hafner D; Schmitz FJ; Wichelhaus TA;
    Int J Antimicrob Agents; 2004 Jun; 23(6):577-81. PubMed ID: 15194128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of methicillin and mupirocin resistance in Staphylococcus aureus isolates using conventional and molecular methods: a descriptive study from a burns unit with high prevalence of MRSA.
    Krishnan PU; Miles K; Shetty N
    J Clin Pathol; 2002 Oct; 55(10):745-8. PubMed ID: 12354799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of high-level mupirocin-resistant Staphylococcus aureus in a tertiary care facility.
    Irizarry L; Rupp J; Griffith J
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1967-8. PubMed ID: 8843318
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study.
    Biedenbach DJ; Bouchillon SK; Johnson SA; Hoban DJ; Hackel M
    Clin Ther; 2014 Jun; 36(6):953-60. PubMed ID: 24835558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural changes induced by mupirocin in Staphylococcus aureus cells.
    Thomas DG; Hann AC; Day MJ; Wilson JM; Russell AD
    Int J Antimicrob Agents; 1999 Sep; 13(1):9-14. PubMed ID: 10563399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low prevalence of mupirocin resistance in Belgian Staphylococcus aureus isolates collected during a 10 year nationwide surveillance.
    Nagant C; Deplano A; Nonhoff C; De Mendonça R; Roisin S; Dodémont M; Denis O
    J Antimicrob Chemother; 2016 Jan; 71(1):266-7. PubMed ID: 26377863
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
    Woodford N; Afzal-Shah M; Warner M; Livermore DM
    J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of mupA Evigene in comparison to disk diffusion for detection of high-level mupirocin resistance in clinical isolates of Staphylococcus aureus.
    Acuna-Villaorduna C; Hardwick MJ; Goucher S; Waga M; Shoham S
    J Clin Microbiol; 2010 Aug; 48(8):2953-4. PubMed ID: 20519465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.